Asterias Biotherapeutics Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
31
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Asterias Biotherapeutics General Information
Description
Developer of regenerative medicine for neurology and oncology applications based in Fremont, California. The company is an immunotherapy platform to teach cancer patients' immune systems to attack their tumors.
Contact Information
Website
www.asteriasbiotherapeutics.comCorporate Office
- 6300 Dumbarton Circle
- Fremont, CA 94555
- United States
Corporate Office
- 6300 Dumbarton Circle
- Fremont, CA 94555
- United States
Asterias Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Asterias Biotherapeutics Comparisons
Industry
Financing
Details
Asterias Biotherapeutics Competitors (84)
One of Asterias Biotherapeutics’s 84 competitors is Sana Biotechnology, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sana Biotechnology | Formerly VC-backed | Seattle, WA | ||||
| Clearside Biomedical | Formerly VC-backed | Alpharetta, GA | ||||
| Capricor Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Immunocore Holdings | Formerly VC-backed | Abingdon, United Kingdom | ||||
| Tenaya Therapeutics | Formerly VC-backed | South San Francisco, CA |
Asterias Biotherapeutics Patents
Asterias Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240382529-A1 | Compositions and methods for treating spinal cord injuries | Pending | 28-Jan-2022 | ||
| WO-2023147512-A2 | Compositions and methods for treating spinal cord injuries | Inactive | 28-Jan-2022 | ||
| WO-2023147512-A3 | Compositions and methods for treating spinal cord injuries | Inactive | 28-Jan-2022 | ||
| AU-2022212124-A1 | Compositions and methods for treating spinal cord injuries | Pending | 28-Jan-2021 | ||
| CA-3210070-A1 | Compositions and methods for treating spinal cord injuries | Pending | 28-Jan-2021 | A61K35/30 |
Asterias Biotherapeutics Signals
Asterias Biotherapeutics FAQs
-
When was Asterias Biotherapeutics founded?
Asterias Biotherapeutics was founded in 2012.
-
Where is Asterias Biotherapeutics headquartered?
Asterias Biotherapeutics is headquartered in Fremont, CA.
-
What is the size of Asterias Biotherapeutics?
Asterias Biotherapeutics has 31 total employees.
-
What industry is Asterias Biotherapeutics in?
Asterias Biotherapeutics’s primary industry is Drug Discovery.
-
Is Asterias Biotherapeutics a private or public company?
Asterias Biotherapeutics is a Private company.
-
What is Asterias Biotherapeutics’s current revenue?
The current revenue for Asterias Biotherapeutics is .
-
Who are Asterias Biotherapeutics’s competitors?
Sana Biotechnology, Clearside Biomedical, Capricor Therapeutics, Immunocore Holdings, and Tenaya Therapeutics are some of the 84 competitors of Asterias Biotherapeutics.
-
When was Asterias Biotherapeutics acquired?
Asterias Biotherapeutics was acquired on 11-Mar-2019.
-
Who acquired Asterias Biotherapeutics?
Asterias Biotherapeutics was acquired by Lineage Cell Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process